Correlation Between AstraZeneca PLC and Charter Communications

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both AstraZeneca PLC and Charter Communications at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining AstraZeneca PLC and Charter Communications into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between AstraZeneca PLC ADR and Charter Communications Cl, you can compare the effects of market volatilities on AstraZeneca PLC and Charter Communications and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in AstraZeneca PLC with a short position of Charter Communications. Check out your portfolio center. Please also check ongoing floating volatility patterns of AstraZeneca PLC and Charter Communications.

Diversification Opportunities for AstraZeneca PLC and Charter Communications

-0.83
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between AstraZeneca and Charter is -0.83. Overlapping area represents the amount of risk that can be diversified away by holding AstraZeneca PLC ADR and Charter Communications Cl in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Charter Communications and AstraZeneca PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on AstraZeneca PLC ADR are associated (or correlated) with Charter Communications. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Charter Communications has no effect on the direction of AstraZeneca PLC i.e., AstraZeneca PLC and Charter Communications go up and down completely randomly.

Pair Corralation between AstraZeneca PLC and Charter Communications

Assuming the 90 days trading horizon AstraZeneca PLC ADR is expected to under-perform the Charter Communications. But the stock apears to be less risky and, when comparing its historical volatility, AstraZeneca PLC ADR is 1.81 times less risky than Charter Communications. The stock trades about -0.08 of its potential returns per unit of risk. The Charter Communications Cl is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  28,579  in Charter Communications Cl on September 1, 2024 and sell it today you would earn a total of  10,816  from holding Charter Communications Cl or generate 37.85% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthSignificant
Accuracy96.92%
ValuesDaily Returns

AstraZeneca PLC ADR  vs.  Charter Communications Cl

 Performance 
       Timeline  
AstraZeneca PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AstraZeneca PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in December 2024. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.
Charter Communications 

Risk-Adjusted Performance

7 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Charter Communications Cl are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Charter Communications unveiled solid returns over the last few months and may actually be approaching a breakup point.

AstraZeneca PLC and Charter Communications Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with AstraZeneca PLC and Charter Communications

The main advantage of trading using opposite AstraZeneca PLC and Charter Communications positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if AstraZeneca PLC position performs unexpectedly, Charter Communications can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Charter Communications will offset losses from the drop in Charter Communications' long position.
The idea behind AstraZeneca PLC ADR and Charter Communications Cl pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Pair Correlation module to compare performance and examine fundamental relationship between any two equity instruments.

Other Complementary Tools

Content Syndication
Quickly integrate customizable finance content to your own investment portal
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Fundamental Analysis
View fundamental data based on most recent published financial statements